Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines

Autor: Hans Ramsay, H. A. Jaaskela-Saari, Kalevi Kairemo, Reidar Grénman
Rok vydání: 1998
Předmět:
Zdroj: International journal of radiation biology. 73(5)
ISSN: 0955-3002
Popis: Purpose: To investigate the cytotoxicity of bleomycin (BLM), two Auger-emitting bleomycin complexes (indium-111 ( 111 In)-BLMC) and 111 InCl 3 in three squamous cell cancer (SCC) cell lines. Material and methods: Three recently established SCC cell lines were investigated using the 96-well clonogenic assay. Concentrations causing 50% inhibition in cell survival (IC 50 ) were calculated for BLM and two specific activities of 111 In-BLMC (40 MBq/mg BLM (low) and 195 MBq/mg BLM (high)). Results: 111 In-BLMC (low) was the most toxic to the SCC cell lines. 111 In-BLMC containing 4.9-fold more activity of 'In (195 MBq/mg BLM) was more effective than BLM (p = 0.0029), but not as toxic as 111 In-BLMC (low) (p=0.0023). UT-SCC-19A had a IC 50 value for BLM as low as 4.1 nM, whereas IC 50 values for 111 In-BLMC (low) and 111 In-BLMC (high) were 2.0 nM and 2.6 nM, respectively. The most chemoresistant cell line UT-SCC-12A had a IC 50 value for BLM of 18.8 nM, for 111 In-BLMC (low) 10.7 nM and for 111 In-BLMC (high) 12.7 nM. 111 InCl 3 had no cell killing effect. Conclusions: This study shows that 111 In-BLMC is superior in SCC cell killing compared with BLM. These data provide the basis for further clinical investigations of 111 In-BLMC.
Databáze: OpenAIRE